-
Mashup Score: 0
After an inspiring opening plenary, “Back to the Future of AMR,” co-chaired by Glen Westall, FRACP, PhD from Alfred Hospital in Melbourne, and Meghan Aversa, MD, from the University of Toronto, engaged attendees seeking an update about the current state of knowledge on the detection, pathogenesis, and treatment of antibody-mediated rejection (AMR). Jake Natalini, MD, MSCE, from NYU Langdon…
Source: www.ishlt.orgCategories: Cardiology News and Journals, Latest HeadlinesTweet
-
Mashup Score: 0ISHLT: The International Society for Heart & Lung Transplantation - Upcoming Webinars - 11 month(s) ago
This website uses cookies to ensure the best possible web experience. By continuing and using the site, you consent to the use of cookies. If you wish to disable them or to learn more about how we use cookies, please view our Cookies Policy. Modernizing Your Transplant Program with an Integrated…
Source: ishlt.orgCategories: Cardiology News and Journals, Latest HeadlinesTweet-
📅🫁 Next week: join #ISHLT + #LungBioengineering for a webinar on how to Modernize your #LungTransplant Program with an Integrated #EVLP Service. The webinar is free thanks to Lung Bioengineering, and will be viewable ondemand if you can't attend live. 🔗https://t.co/fGjaAZi0JF https://t.co/Kq5wpZUH3P
-
-
Mashup Score: 2JHLT: The Podcast: Episode 27: March 2023 - 1 year(s) ago
This month’s JHLT: The Podcast is hosted by Digital Media Editor David Schibilsky, MD, who leads a discussion of two studies from the March issue of The Journal of Heart and Lung Transplantation—and the first authors who presented them. First, the editors explore a study entitled “,” which comes from Hadinnapola and colleagues at the Papworth group in Cambridge, UK. The editors welcome…
Source: thejhlt.libsyn.comCategories: Cardiology News and Journals, Latest HeadlinesTweet
-
Mashup Score: 4JHLT: The Podcast: Episode 27: March 2023 - 1 year(s) ago
This month’s JHLT: The Podcast is hosted by Digital Media Editor David Schibilsky, MD, who leads a discussion of two studies from the March issue of The Journal of Heart and Lung Transplantation—and the first authors who presented them. First, the editors explore a study entitled “,” which comes from Hadinnapola and colleagues at the Papworth group in Cambridge, UK. The editors welcome…
Source: thejhlt.libsyn.comCategories: Cardiology News and Journals, Latest HeadlinesTweet
-
Mashup Score: 0L-alanyl-L-glutamine modified perfusate improves human lung cell functions and extend porcine ex vivo lung perfusion - 1 year(s) ago
The clinical application of normothermic ex vivo lung perfusion (EVLP) has increased donor lung utilization for transplantation through functional assessment. To develop it as a platform for donor lung repair, reconditioning and regeneration, the perfusate should be modified to support the lung during extended EVLP.
Categories: Cardiology News and Journals, Latest HeadlinesTweet
-
Mashup Score: 0
In the US, only 23% of lungs offered for transplantation are transplanted. Ex vivo lung perfusion (EVLP) allows for evaluation of additional donor lungs; its adoption has been limited by resources and expertise. Dedicated facilities with a centralized lung evaluation system (CLES) could expand access to EVLP.
Categories: Cardiology News and Journals, Latest HeadlinesTweet
-
Mashup Score: 0Continuous Endogenous Exhaled CO Monitoring by Laser Spectrometer in Human EVLP Before Lung Transplantation - 2 year(s) ago
Endogenous production of carbon monoxide (CO) is affected by inflammatory phenomena and ischemia-reperfusion injury. Precise measurement of exhaled endogenous CO (eCO) is possible thanks to a laser spectrometer (ProCeas® from AP2E company). We assessed eCO levels of human lung grafts during the normothermic Ex-Vivo Lung Perfusion (EVLP). ProCeas® was connected in bypass to the ventilation…
Source: FrontiersCategories: Latest Headlines, TransplantationTweet
-
Mashup Score: 0Inflammatory responses in lungs from donation after brain death: Mechanisms and potential therapeutic targets - 3 year(s) ago
The vast majority of lungs used in clinical transplantation are donated after brain death (DBD). The utilization of DBD lungs is low due to brain death-induced lung injury. Moreover, inflammatory responses in DBD lungs used for transplantation contribute to ischemia-reperfusion injury and primary graft dysfunction. Work from human observational studies has demonstrated overexpression of…
Categories: Cardiology News and Journals, Latest HeadlinesTweet-
September Issue Invited Review: Most donated lungs come from brain dead donors. Brain death-induced inflammation affects donor utilization. ID of mechanisms driving inflammation may allow for lung repair prior to transplant. https://t.co/W2W5KWihDh @aaronkkwong @LiuMingyao #EVLP https://t.co/ekZS2bay3F
-
-
Mashup Score: 0Continuing progress toward improved lung assessment - 3 year(s) ago
Lung transplantation is an effective therapy for end-stage lung disease.1 As in other types of solid organ transplants, there are limitations to the number of organs available for transplantation. Therefore, efforts to expand the donor pool through use of extended criteria and circulatory death donors are needed.2-8 More recently, use of ex vivo lung perfusion (EVLP) has further expanded the…
Categories: Cardiology News and Journals, Latest HeadlinesTweet
The Lung team - @dralourdeschac1 and @RAKlingbeilDNP - spent Saturday at #ISHLT2023 covering COVID in #LungTx, improvements in #EVLP, #LungTx rejection, and advances in fungal biology. https://t.co/fPlU2OcnkN https://t.co/dsU7Wl4M5L